The role of the kallikrein-kinin system genes in the salt sensitivity of blood pressure

American Journal of Epidemiology

Volumn 176, Issue SUPPL. 7, 2012, Pages

  Gu, Dongfeng ^a   Zhao, Qi ^b   Kelly, Tanika N ^b   Hixson, James E ^c   Rao, Dabeeru C ^d   Cao, Jie ^a   Chen, Jing ^e   Li, Jianxin ^a   Chen, Jichun ^a   Ji, Xu ^f   Hu, Dongsheng ^g   Wang, Xushan ^h   Liu, De Pei ^a   He, Jiang ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b TULANE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Xinle Traditional Chinese Medicine Hospital   (China)

^g Shenzhen University   (China)

^h Ganyu Center for Disease Control and Prevention   (China)

Author keywords

Blood pressure; Genetics; Kallikreins; Kinins; Polymorphism; Sodium dietary

Indexed keywords

BRADYKININ B2 RECEPTOR; CYSTEINE; ENDOTHELIN CONVERTING ENZYME; GLYCINE; KALLIKREIN; KININ;

ALLELE; BLOOD SYSTEM DISORDER; COHORT ANALYSIS; DIET; EXPERIMENTAL STUDY; GENETIC VARIATION; PARTICIPATORY APPROACH; PHENOTYPE; POLYMORPHISM; PUBLIC HEALTH; SALT; SODIUM; SPATIOTEMPORAL ANALYSIS;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE SALT SENSITIVITY; CHINESE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HIGH SODIUM INTAKE; HUMAN; HUMAN EXPERIMENT; KALLIKREIN KININ SYSTEM; MALE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM RESTRICTION; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE;

ADULT; ALLELES; ASPARTIC ACID ENDOPEPTIDASES; BLOOD PRESSURE; CHINA; DIET, SODIUM-RESTRICTED; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; KALLIKREIN-KININ SYSTEM; MALE; METALLOENDOPEPTIDASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, BRADYKININ B2; SODIUM, DIETARY;

CHINA;

EID: 84867307328     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws277     Document Type: Article

References (38)

1. Morimoto A, Uzu T, Fujii T, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350(9093):1734- 1737.
2. Weinberger MH, Fineberg NS, Fineberg SE, et al. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001;37(2 part 2):429-432.
3. Banno M, Hanada H, Kamide K, et al. Association of genetic polymorphisms of endothelin-converting enzyme-1 gene with hypertension in a Japanese population and rare missense mutation in preproendothelin-1 in Japanese hypertensives. Hypertens Res. 2007;30(6):513-520.
4. Svetkey LP, McKeown SP, Wilson AF. Heritability of salt sensitivity in black Americans. Hypertension. 1996;28(5): 854-858.
5. Sharma JN. Hypertension and the bradykinin system. Curr Hypertens Rep. 2009;11(3):178-181.
6. Sharma JN. The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection. Inflammopharmacology. 2005;12(5-6):591-596.
7. Marcondes S, Antunes E. The plasma and tissue kininogenkallikrein-kinin system: role in the cardiovascular system. Curr Med Chem Cardiovasc Hematol Agents. 2005;3(1):33-44.
8. Majima M, Yoshida O, Mihara H, et al. High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats. Hypertension. 1993;22(5):705-714.
9. Alfie ME, Yang XP, Hess F, et al. Salt-sensitive hypertension in bradykinin B2 receptor knockout mice. Biochem Biophys Res Commun. 1996;224(3):625-630.
10. Bonner G, Thieven B, Rutten H, et al. Renal kallikrein is a determinant of salt sensitivity. J Hypertens Suppl. 1993; 11(5):S210-S211.
11. Madeddu P, Varoni MV, Demontis MP, et al. Kallikrein-kinin system and blood pressure sensitivity to salt. Hypertension. 1997;29(1 pt 2):471-477.
12. Campbell DJ. The kallikrein-kinin system in humans. Clin Exp Pharmacol Physiol. 2001;28(12):1060-1065.
13. Kakoki M, Smithies O. The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int. 2009;75(10): 1019-1030.
14. Marceau F, Hess JF, Bachvarov DR. The B1 receptors for kinins. Pharmacol Rev. 1998;50(3):357-386.
15. GenSalt: rationale, design, methods, baseline characteristics of study participants. J Hum Hypertens. 2007;21(8):639-646.
16. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993; 88(5):2460-2470.
17. Gu D, Kelly TN, Hixson JE, et al. Genetic variants in the renin-angiotensin-aldosterone system and salt sensitivity of blood pressure. J Hypertens. 2010;28(6):1210-1220.
18. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575.
19. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998;63(1):259-266.
20. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289-300.
21. Svetkey LP, Harris EL, Martin E, et al. Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system. Am J Hypertens. 2011;24(2): 209-217.
22. Sharma JN, Uma K, Noor AR, et al. Blood pressure regulation by the kallikrein-kinin system. Gen Pharmacol. 1996;27(1):55-63.
23. Katori M, Majima M. A missing link between a high salt intake and blood pressure increase. J Pharmacol Sci. 2006;100(5):370-390.
24. Zhao W, Wang Y, Wang L, et al. Gender-specific association between the kininogen 1 gene variants and essential hypertension in Chinese Han population. J Hypertens. 2009;27(3):484-490.
25. Zhao W, Wang L, Lu X, et al. A coding polymorphism of the kallikrein 1 gene is associated with essential hypertension: a tagging SNP-based association study in a Chinese Han population. J Hypertens. 2007;25(9):1821-1827.
26. Hua H, Zhou S, Liu Y, et al. Relationship between the regulatory region polymorphism of human tissue kallikrein gene and essential hypertension. J Hum Hypertens. 2005; 19(9):715-721.
27. Jiang S, Hsu YH, Venners SA, et al. Effects of protein coding polymorphisms in the kallikrein 1 gene on baseline blood pressure and antihypertensive response to irbesartan in Chinese hypertensive patients. J Hum Hypertens. 2011;25(5): 327-333.
28. Lu X, Zhao W, Huang J, et al. Common variation in KLKB1 and essential hypertension risk: tagging-SNP haplotype analysis in a case-control study. Hum Genet. 2007;121(3-4): 327-335.
29. Funalot B, Courbon D, Brousseau T, et al. Genes encoding endothelin-converting enzyme-1 and endothelin-1 interact to influence blood pressure in women: the EVA Study. J Hypertens. 2004;22(4):739-743.
30. Cui J, Melista E, Chazaro I, et al. Sequence variation of bradykinin receptors B1 and B2 and association with hypertension. J Hypertens. 2005;23(1):55-62.
31. Gainer JV, Brown NJ, Bachvarova M, et al. Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans. Am J Hypertens. 2000;13(12):1268-1273.
32. Pretorius MM, Gainer JV, Van Guilder GP, et al. The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance. Clin Pharmacol Ther. 2008;83(1):122-129.
33. Freitas SR, Pereira AC, Floriano MS, et al. Insertion/deletion polymorphism of the bradykinin type 2 receptor gene influence diastolic blood pressure. J Hum Hypertens. 2009; 23(8):553-555.
34. Niu W, Qi Y, Gao P, et al. A meta-analysis of the bradykinin B2 receptor gene ?58C/T polymorphism with hypertension. Clin Chim Acta. 2010;411(5-6):324- 328.
35. Fu Y, Katsuya T, Matsuo A, et al. Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy. Hypertens Res. 2004; 27(12):933-938.
36. Xu Z, Taylor JA. SNPinfo: integrating GWAS candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009;37(Web server issue):W600-W605.
37. Hoang MV, Turner AJ. Novel activity of endothelinconverting enzyme: hydrolysis of bradykinin. Biochem J. 1997;327(pt 1):23-26.
38. Funke-Kaiser H, Reichenberger F, Kopke K, et al. Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation. Hum Mol Genet. 2003;12(4):423-433.